Growth Metrics

Xtant Medical Holdings (XTNT) Raw Materials (2019 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Raw Materials for 7 consecutive years, with $5.6 million as the latest value for Q3 2025.

  • Quarterly Raw Materials fell 21.9% to $5.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Sep 2025, down 21.9% year-over-year, with the annual reading at $6.6 million for FY2024, 8.9% down from the prior year.
  • Raw Materials for Q3 2025 was $5.6 million at Xtant Medical Holdings, up from $5.4 million in the prior quarter.
  • The five-year high for Raw Materials was $7.3 million in Q4 2023, with the low at $3.8 million in Q1 2021.
  • Average Raw Materials over 5 years is $5.9 million, with a median of $5.6 million recorded in 2022.
  • The sharpest move saw Raw Materials skyrocketed 49.4% in 2021, then decreased 23.22% in 2025.
  • Over 5 years, Raw Materials stood at $5.6 million in 2021, then rose by 0.27% to $5.6 million in 2022, then increased by 29.16% to $7.3 million in 2023, then decreased by 8.9% to $6.6 million in 2024, then dropped by 15.42% to $5.6 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $5.6 million, $5.4 million, and $5.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.